Agazisiran (sodium)
Agazisiran sodium, a siRNA, is a complement factor B synthesis reducer.
Product Specifications
UNSPSC
12352208
Target
Complement System
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Agazisiran(sodium)]
Molecular Formula
C534H560F15N179Na46O329P44S8
Molecular Weight
17711.00
References & Citations
[1]WHO Drug Information - Vol. 38 , No. 4, 2024
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7027515-01 0.02 mg
Recombinant Nicotiana tomentosiformis Photosystem II CP43 chlorophyll apoprotein (psbC)
Ask
View Details 
MBS7027515-02 0.1 mg
Recombinant Nicotiana tomentosiformis Photosystem II CP43 chlorophyll apoprotein (psbC)
Ask
View Details 
MBS7027515-03 5x 0.1 mg
Recombinant Nicotiana tomentosiformis Photosystem II CP43 chlorophyll apoprotein (psbC)
Ask
View Details 038690 200 µL
MUC1, phosphorylated (T1224) (MUC1, PUM, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin, Episialin, H23AG, Krebs von den Lungen-6, PEMT, Peanut-reactive urinary mucin, Polymorphic epithelial mucin, Tumor-associated epithelial membrane antigen, Tumor-associated mucin, CD227, Mucin-1 subunit alpha, Mucin-1 subunit beta, MUC1-CT)
Ask
View Details